Reaktionsgleichung
[CH3:1][N:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C:6](=O)[N:5]2[CH2:14][CH2:15][CH2:16][CH:4]2[C:3]1=[O:17].CN1C(=O)OC(=O)C2=CC=CC=C12.N1CCC[C@@H]1C(O)=O.B>O1CCCC1.CO>[CH3:1][N:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[CH2:6][N:5]2[CH2:14][CH2:15][CH2:16][CH:4]2[C:3]1=[O:17]Komponenten
7
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
The above compound is obtained when (-)-1,2,3,11 a-tetrahydro-10-methyl-5H-pyrrolo[2,1-c] [1,4] benzodiazepin- 5,11(10H)-dione, melting point 120-122°C. [α]D 25 - 477°, (1.24%, methanol) and (prepared from N-methylisatoic anhydride and D-proline as described in Example 1) is treated with borane in tetrahydrofuran as described in Example 1.
Aufarbeitung
- customThe above compound is obtained
Quellen und Nachweise
- ORD-Eintrag
- ord-ad14593739a846938701f4f516ce75c5
- Quelldatensatz
- uspto-grants-1976_03
- Patentnummer
- US03947408
Verknüpfte Notizen
Wird geladen…